AutoZone Stock Suffers Worst Day in Four Years Despite Earnings Beat Free Fillet Program Offers Lifeline to Maines Groundfishing Industry Amid Inflation South East Water Faces Supply Outages in Kent and Sussex Amid Technical Failure and Scrutiny X Owned by Elon Musk Fined A650000 by Australia for Child Protection Compliance Failures Super Micro Computer SMCI Appoints Matthew Thauberger as Chief Revenue Officer Pentagon Releases Decades of UFO Sightings Potential Implications for Defense and Technology Sectors BeyondSpring Q1 2026 Earnings Narrowing Loss Highlights Pipeline Progress Amid Zero Revenue Polaris Inc PII Q1 2026 Earnings Surprise Profit Turnaround as EPS Blows Past Estimates EVER Q1 2026 Earnings Robust EPS Beat Fueled by Operational Discipline Dream Finders Homes Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market PHAT Q1 2026 Earnings Missed EPS Estimates Amid Ongoing Development Efforts ZBRA Q1 2026 Earnings Earnings Beat Drives Stock Higher Vine Hill Capital Corp II VHCP Nudges Higher as Shares Trade Near Trust Value New Germany Fund GF Gains 22 as Price Approaches Key Resistance Kayne Anderson Energy Infrastructure Fund KYN Edges Lower as It Tests Support Within Tight Trading Range bioAffinity Technologies BIAF Holds Near Support as Minimal Decline Reflects Cautious Trading Forum Energy Technologies FET Slides 239 Amid Sector Weakness Key Support Levels in Focus ZTO Q1 2026 Earnings Strong EPS Performance Amid Limited Disclosure ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy Eagle Point Credit Company Inc ECC Q4 2025 Earnings EPS Surpasses Estimates Stock Gains 21 Birchtech Corp BCHT Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Rises 116 HYPD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower HASI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Business Model Palo Alto Networks Outpaces Palantir by 60 YeartoDate Potential Index Rebalancing Questions Arise AZTR Q1 2026 Earnings Massive EPS Miss Exceeds Expectations as Stock Declines Nearly 4 Candel Therapeutics CADL Edges Higher Holds Above Key Support Level